1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with irinotecan in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (irinotecan) | Trials (irinotecan) | Recent Studies (post-2010) (irinotecan) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 8,002 | 1,885 | 3,752 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | irinotecan (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 2.7 | |
| Interstitial collagenase | Homo sapiens (human) | 6.06 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 1.556 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 3.171 | |
| Acetylcholinesterase | Homo sapiens (human) | 1.827 | |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 7.9 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 4.7667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murota, M; Sakai, H; Suzuki, T; Takahashi, Y; Takeguchi, N | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and irinotecan
| Article | Year |
|---|---|
Nitric oxide-induced Cl- secretion in isolated rat colon is mediated by the release of thromboxane A2.
Topics: Animals; Camptothecin; Chlorides; Colon; Cyclic GMP; Enzyme Inhibitors; Female; Gene Expression; Imidazoles; Intestinal Mucosa; Irinotecan; Membrane Potentials; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Parasympathomimetics; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; RNA, Messenger; Thromboxane A2 | 2002 |